Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sural Nerve | 1 | 2011 | 46 | 0.340 |
Why?
|
| Electrophysiology | 1 | 2011 | 249 | 0.320 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 60 | 0.320 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 132 | 0.310 |
Why?
|
| Myelin Basic Protein | 4 | 2009 | 67 | 0.220 |
Why?
|
| Multiple Sclerosis | 6 | 2009 | 389 | 0.220 |
Why?
|
| Myotonic Dystrophy | 2 | 2012 | 74 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 1001 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 60 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 1712 | 0.090 |
Why?
|
| Reflex | 1 | 2011 | 35 | 0.080 |
Why?
|
| Neural Conduction | 1 | 2011 | 83 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2009 | 56 | 0.080 |
Why?
|
| Osteopontin | 1 | 2009 | 54 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2009 | 125 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2009 | 500 | 0.070 |
Why?
|
| Action Potentials | 1 | 2011 | 471 | 0.070 |
Why?
|
| Pain | 1 | 2011 | 429 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 239 | 0.070 |
Why?
|
| Peptide Fragments | 3 | 2009 | 687 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 633 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 538 | 0.060 |
Why?
|
| Gene Expression | 1 | 2010 | 1486 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2088 | 0.060 |
Why?
|
| Autoantigens | 1 | 2004 | 100 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 57 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2003 | 26 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 271 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 196 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1483 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 60 | 0.040 |
Why?
|
| Herpesvirus 6, Human | 1 | 2002 | 53 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 510 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2002 | 452 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 235 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 338 | 0.040 |
Why?
|
| Middle Aged | 6 | 2012 | 28370 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6783 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4666 | 0.040 |
Why?
|
| Adult | 6 | 2012 | 31095 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 9979 | 0.030 |
Why?
|
| Vaccination | 1 | 2002 | 1051 | 0.030 |
Why?
|
| Male | 7 | 2012 | 64453 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 1172 | 0.030 |
Why?
|
| Female | 7 | 2012 | 70325 | 0.030 |
Why?
|
| Thiadiazoles | 1 | 2012 | 4 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2012 | 11 | 0.020 |
Why?
|
| Lymphocyte Count | 2 | 2004 | 119 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2012 | 58 | 0.020 |
Why?
|
| Lithium | 1 | 2012 | 66 | 0.020 |
Why?
|
| CHO Cells | 1 | 2012 | 151 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 61 | 0.020 |
Why?
|
| Humans | 9 | 2012 | 130376 | 0.020 |
Why?
|
| Aged | 1 | 2011 | 20863 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 361 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2012 | 83 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 102 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 242 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2009 | 2895 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 43 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 360 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mice | 3 | 2012 | 18219 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2009 | 35 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2009 | 45 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1572 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2009 | 84 | 0.020 |
Why?
|
| Interleukins | 1 | 2009 | 121 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2010 | 310 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 828 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 410 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 228 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2009 | 343 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 373 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 870 | 0.010 |
Why?
|
| Animals | 3 | 2012 | 33846 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 2333 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2004 | 71 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2004 | 111 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2003 | 46 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2003 | 41 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2003 | 65 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 220 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 110 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 331 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 152 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 718 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1921 | 0.010 |
Why?
|
| Virion | 1 | 2002 | 116 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3712 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 785 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 2002 | 140 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 636 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1206 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4714 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 216 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 464 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 541 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 2557 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2397 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3469 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1444 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 2193 | 0.010 |
Why?
|
| Brain | 1 | 2002 | 3174 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 12836 | 0.000 |
Why?
|